Sustainability Leader SEKISUI Diagnostics has shown a strong sustainability focus with EcoVadis Silver medals for multiple years, indicating a commitment to responsible operations that can be leveraged in conversations with healthcare buyers prioritizing ESG.

Expansion and Capacity Recent investments to expand cGMP microbial capacity in the UK and Europe, along with rapid test launches like the OSOM RSV Test, suggest capacity growth and product breadth that can support upsell opportunities in high-demand infectious disease and rapid diagnostics.

Global Footprint A six-site footprint across four countries with R&D and manufacturing on three continents enables regional and cross-border sales strategies, as well as localized service and supply assurances for global customers.

Competitive Position With a leading presence in rapid tests in the US and high-throughput coagulation systems in Japan, SEKISUI Diagnostics occupies a strategic niche in fast-turnaround diagnostics and specialty biochemicals, offering cross-sell potential to labs and hospitals seeking integrated solutions.

Strategic Partnerships Recent partnerships with Microbix and PEI BioAlliance indicate openness to strategic collaborations and ecosystem play, presenting opportunities for co-developed assays, distribution deals, and expanded market access in North America and Europe.